Results 101 to 110 of about 2,720,543 (229)

[Secondary hyperparathyroidism].

open access: yesChirurgia (Bucharest, Romania : 1990), 1996
Secondary (renal) hyperparathyroidism appears in chronic renal failure, sometimes in patients on chronic dialysis. Other causes includes rickets and osteomalacia. These diseases are associated with poor calcium and vitamin D absorbtion from the small bowel.
M R, Diaconescu   +5 more
openaire   +1 more source

Hypercalcemia in a Patient With Spinal Tuberculosis and Aspergillus Co‐Infection: A Case‐Report

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 9, September 2026.
ABSTRACT Background Tuberculosis (TB), one of the leading infectious causes of mortality worldwide, may disseminate hematogenously and result in extrapulmonary manifestations. Spinal tuberculosis (ST) is an uncommon but serious form of extrapulmonary TB.
Negin Parsa   +2 more
wiley   +1 more source

Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults

open access: yesObesity, Volume 34, Issue S2, Page 119-131, September 2026.
ABSTRACT Objective This study aimed to evaluate the association of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) with risks of osteoporosis, major osteoporotic fractures, and degenerative musculoskeletal disorders in nondiabetic adults with obesity compared with other obesity medications.
Jie‐Syuan Wu   +5 more
wiley   +1 more source

A Swelling in the Mouth in a Chronic Hemodialysis Patient

open access: yesCase Reports in Nephrology, 2016
Oral manifestations of severe secondary hyperparathyroidism include maxillary and mandibular deformities, brown tumors, dental abnormalities, and metastatic calcification of soft tissues.
Arnaud Devresse   +3 more
doaj   +1 more source

Understanding Low Motivation for Treatment in Primary Hyperparathyroidism: A Qualitative Study of Patients and Providers in the United States

open access: yesWorld Journal of Surgery, Volume 50, Issue 9, Page 2669-2676, September 2026.
Untreated PHPT represents a major health service failure driven in part by poor disease literacy and constrained primary care encounters. ABSTRACT Background Two thirds of patients with primary hyperparathyroidism (PHPT) go untreated, risking progressive osteoporosis, fractures, and nephrolithiasis.
John O'Connor   +4 more
wiley   +1 more source

Bradycardia secondary to primary hyperparathyroidism

open access: yesJournal of International Medical Research, 2019
Clinical doctors rarely associate hyperparathyroidism with significant bradyarrhythmia. We report a rare case of a patient initially misdiagnosed with primary sick sinus syndrome, which was eventually shown to be secondary to primary hyperparathyroidism.
Fei Liu   +3 more
doaj   +1 more source

Prevalence of Vitamin D Deficiency and Its Association With PTH and Type 1 Diabetes Mellitus (T1DM) in a Multicultural Pediatric Population in the United Arab Emirates, 2023

open access: yesJournal of Diabetes, Volume 18, Issue 9, September 2026.
This cross‐sectional study conducted in the United Arab Emirates investigated Vitamin D status in 102 pediatric patients (ages 3–18) with Type 1 Diabetes Mellitus in the United Arab Emirates, revealing a high prevalence of Vitamin D insufficiency that frequently presents alongside normal parathyroid hormone levels.
Mariam K. Ibrahim   +4 more
wiley   +1 more source

Hyperparathyroidism secondary to hyperaldosteronism

open access: yes, 2010
Introduction: Hyperparathyroidism has been associated with essential hypertension. In rats, volume expansion, the deoxycorticosterone (DOC)-salt hypertension model and primary aldosteronism cause a reduction in plasma calcium levels and secondary ...
Fortina F., Bellosta S.
core   +1 more source

SGLT2 Inhibitors Are Associated With Suppression of the Sema3A/NRP1/Plexin‐A1 Signaling Axis in Postmenopausal Women With Type 2 Diabetes: Evidence From Propensity Score‐Matched Analysis

open access: yesJournal of Diabetes, Volume 18, Issue 9, September 2026.
Propensity score‐matched comparison of 23 SGLT2 inhibitor users and 23 non‐users revealed that SGLT2 inhibitor use was associated with significantly lower Neuropilin‐1 (NRP1) levels (74.25 vs. 87.61 ng/mL; p = 0.015) and a higher Sema3A/NRP1 ratio (0.14 vs.
Sertas Erarslan, Burcu Cosgun Bora
wiley   +1 more source

Paricalcitol for secondary hyperparathyroidism in renal transplantation

open access: yes, 2015
Secondary hyperparathyroidism contributes to post-transplant CKD mineral and bone disorder. Paricalcitol, a selective vitamin D receptor activator, decreased serum parathyroid hormone levels and proteinuria in patients with secondary hyperparathyroidism.
A. Perna   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy